__NUXT_JSONP__("/drugs/Palladium_Pd-103", (function(a,b,c,d){return {data:[{drug:{slug:b,emaEpar:[],fdaDrugLabel:[],id:b,nciThesaurus:{casRegistry:a,chebiId:a,chemicalFormula:a,definition:"A radioisotope of the metal palladium used in brachytherapy implants or 'seed'. With a half-life of 17 days, palladium 103 administered with brachytherapy allows continuous, tumor-site specific low-energy irradiation to the tumor cell population while sparing normal adjacent tissues from radiotoxicity.",fdaUniiCode:"68QTV136DF",identifier:"C2550",preferredName:c,semanticType:"Element, Ion, or Isotope",subclassOf:["C799"],synonyms:["PALLADIUM PD-103","Palladium Pd 103",c,"Palladium-103","Pd 103","radioactive palladium"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FPalladium_Pd-103",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("","Palladium_Pd-103","Palladium Pd-103","2021-10-30T13:37:47.583Z")));